WZR-54741-52937 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-28
Dose 1 — Pfizer-BioNTech
2021-02-19
Dose 2 — Pfizer-BioNTech
2021-10-13
Dose 3 — Pfizer-BioNTech
2021-10-20
Registered in v-safe
2021-10-20
Survey response — day 7, dose 3
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-10-27
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-05
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-01-12
Survey response — 3 months, dose 3
MedDRA: Adverse reaction, Pregnancy — Feeling: Fair

Free text: Increased symptoms likely related to pregnancy

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-28	Pfizer-BioNTech	No
2	2021-02-19	Pfizer-BioNTech	No
3	2021-10-13	Pfizer-BioNTech	No

Free text

Release 10 — day 7, dose 3

2021-10-20

Systemic reaction (other): Pregnant

Release 10 — 3 months, dose 3

2022-01-12

Symptoms: Increased symptoms likely related to pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse reaction	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release